Using the SEER-Medicare database, we found negative association between Medicare claim processors“related physician's chemotherapy reimbursement and their prescription of granulocyte colony-stimulating factor for non-Hodgkin lymphoma patients.
Xiaoyun Pan, PhD
Advertisement
Articles by Xiaoyun Pan, PhD
Advertisement
Latest Updated Articles
- Medicare Claim Processors' Reimbursement and G-CSF Choice Among Non-Hodgkin Lymphoma Patients
Published: August 21st 2013 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Emerging Biomarkers Open New Frontiers in Lung Cancer Therapy
2
Transforming HER2+ Metastatic Breast Cancer Treatment With Targeted ADC Therapy
3
Dato-DXd Doubles Response Rates and Extends Survival in First-Line Metastatic TNBC
4
Targeted α-Particle Radioligand Therapy Shows Promising Activity, Low Toxicity in SSTR2-Positive Neuroendocrine Tumors
5
